Wednesday, March 25, 2015

StemCells (STEM) Has a New President/COO

StemCells (STEM) has a new President and Chief Operating Officer. Ian Massey has over 30 years of "pharmaceutical industry experience in all phases of product development." The question that I ask myself: Does this guy join a loser?
"I believe that the Company's technology has the potential to be a game changer that will dramatically improve the standard of care for patients with an array of CNS disorders for which there are currently no treatments. I am thrilled to be joining StemCells at this important and exciting time for the Company," said Dr. Massey.

STEM closed yesterday (02015.03.24) at $1.03. 52-week range: $0.84 - $2.43.

No comments:

Post a Comment